therapeutics Early signs

Could a transplant drug help people age better?

Rapamycin — originally used to prevent organ rejection — blocks a molecular switch in your cells that controls growth and repair. In animals it reliably extends lifespan. Human trials are underway to see if low doses can improve immune function and reduce age-related decline.

Where it stands Strong animal evidence; human trials are promising but not yet conclusive

Linked articles
1
Tracked since
Mar 2026

Articles covering this

1 article, newest first
  1. The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity - Cureus
    Mixed